Technical Analysis for MYOV - Myovant Sciences Ltd.

Grade Last Price % Change Price Change
grade D 13.88 -5.06% -0.74
MYOV closed down 5.06 percent on Friday, January 17, 2020, on 24 percent of normal volume.
Earnings due: Feb 5
*** please verify all earnings dates ***

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Down
Historical MYOV trend table...

Date Alert Name Type % Chg
Outside Day Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Bullish Engulfing Bullish -5.06%
Stochastic Buy Signal Bullish -5.06%
Oversold Stochastic Weakness -5.06%
MACD Bearish Centerline Cross Bearish 0.22%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.22%
Oversold Stochastic Weakness 0.22%
Doji - Bullish? Reversal -1.77%
Oversold Stochastic Weakness -1.77%

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Myovant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for women's health diseases and other endocrine-related disorders. Its lead product candidate is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist, for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain, and advanced prostate cancer. The company also intends to develop RVT-602, an oligopeptide kisspeptin analog, for the treatment of female infertility as part of assisted reproduction. Myovant Sciences Ltd. was founded in 2016 and is based in Hamilton, Bermuda. Myovant Sciences Ltd. operates as a subsidiary of Roivant Sciences Ltd.
Chemistry Biopharmaceutical Pain Prostate Cancer Endocrine System Hormones Amines Pyrimidines Gnrh Antagonists Gonadotropin Releasing Hormone Antagonist Roivant Sciences Uterine Fibroids

Is MYOV a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 26.02
52 Week Low 4.15
Average Volume 3,126,578
200-Day Moving Average 10.78
50-Day Moving Average 13.71
20-Day Moving Average 15.02
10-Day Moving Average 14.20
Average True Range 0.94
ADX 19.6
+DI 22.28
-DI 21.50
Chandelier Exit (Long, 3 ATRs ) 14.92
Chandelier Exit (Short, 3 ATRs ) 16.22
Upper Bollinger Band 17.12
Lower Bollinger Band 12.92
Percent B (%b) 0.23
BandWidth 28.00
MACD Line -0.08
MACD Signal Line 0.17
MACD Histogram -0.2476
Fundamentals Value
Market Cap 844.51 Million
Num Shares 60.8 Million
EPS -1.63
Price-to-Earnings (P/E) Ratio -8.52
Price-to-Sales 0.00
Price-to-Book 5.51
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 15.47
Resistance 3 (R3) 15.62 15.23 15.21
Resistance 2 (R2) 15.23 14.83 15.16 15.12
Resistance 1 (R1) 14.56 14.58 14.37 14.41 15.03
Pivot Point 14.17 14.17 14.08 14.10 14.17
Support 1 (S1) 13.50 13.77 13.31 13.35 12.73
Support 2 (S2) 13.11 13.52 13.04 12.64
Support 3 (S3) 12.44 13.11 12.56
Support 4 (S4) 12.29